+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
ERIS

Eris Lifesciences Share Price

₹1,303.50 +14.6 (1.13%)
27.54% Fall from 52W High

03 Sep, 2026 3:58 PM (IST)

Eris Lifesciences live price: ₹1,303.50. It opened at ₹1,320 vs previous close ₹1,289; intraday high/low: ₹1,337/₹1,289. The 50 & 200 DMA stand at ₹1,364.40/₹1,415.30.

Eris Lifesciences Performance

  • Today's Low
  • ₹1,289
  • Today's High
  • ₹1,337
  • 52 Week Low
  • ₹1,200
  • 52 Week High
  • ₹1,799
  • Open Price₹1,320
  • Previous Close₹1,289
  • Volume79,290
  • 50 DMA₹1,364.40
  • 100 DMA₹1,384.50
  • 200 DMA₹1,415.30

Eris Lifesciences Chart

Investment Returns

  • Over 1 Month -3.78%
  • Over 3 Month -4.3%
  • Over 6 Month -4.18%
  • Over 1 Year -26.4%

Smart Investing Starts Here Start SIP with Eris Lifesciences for Steady Growth!

Invest Now

Eris Lifesciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 28.1
  • PEG Ratio
  • 0.4
  • Market Cap Cr
  • 18,064
  • P/B Ratio
  • 4.5
  • Average True Range
  • 35.6
  • EPS
  • 46.5
  • Dividend Yield
  • 0.6
  • MACD Signal
  • -26
  • RSI
  • 37
  • MFI
  • 41.4

Latest Stock News Updates

Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Newspaper Publication

as attached

Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Newspaper Publication

as attached.

Eris Lifesciences Ltd - 540596 - Business Responsibility and Sustainability Reporting (BRSR)

as attached

Eris Lifesciences Financials

Eris Lifesciences Technicals

EMA & SMA

Current Price
₹1,303.50
+ 14.6 (1.13%)
pointer
  • Bearish Moving Average 14
  • Bullish Moving Average 2
  • 20 Day
  • ₹1,331.50
  • 50 Day
  • ₹1,364.40
  • 100 Day
  • ₹1,384.50
  • 200 Day
  • ₹1,415.30

Resistance and Support

1309.7 Pivot Speed
  • R3 1,378.30
  • R2 1,357.50
  • R1 1,330.50
  • S1 1,282.70
  • S2 1,261.90
  • S3 1,234.90

Eris Lifesciences Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-07-29 Quarterly Results
2026-05-20 Audited Results & Interim Dividend
2026-02-13 Quarterly Results
2025-11-24 Preferential issue of shares Inter-alia, To consider the protposal of issuance ofequity shares of the Company by way of a preferential issue for consideration other than cash..
2025-11-12 Quarterly Results
Date Purpose Remarks
2026-05-29 INTERIM Rs.7.21 per share(721%)Interim Dividend
2025-02-13 INTERIM Rs.7.35 per share(735%)Interim Dividend
2022-08-16 INTERIM Rs.7.35 per share(735%)Interim Dividend
2021-08-06 INTERIM Rs.6.01 per share(601%)Interim Dividend
View Eris Lifesciences Dividend History Arrow

Eris Lifesciences Shareholding Pattern

54.14%
19.39%
18.88%
5.76%
1.83%

About Eris Lifesciences

ERIS Lifesciences manufactures, markets, and sells generic drugs. The Company provides a wide range of products in chronic and acute therapy segments which includes capsules, tablets, and sachets. Eris Lifesciences also focuses on hypertension, anti-diabetes, metabolic disorders, lipid lowering, and therapeutic areas. Eris Lifesciences serves the pharmaceutical markets in India. View More
  • NSE Symbol
  • ERIS
  • BSE Symbol
  • 540596
  • ISIN
  • INE406M01024

Similar Stocks to Eris Lifesciences

Eris Lifesciences FAQs

Eris Lifesciences share price is ₹1,303 As on 04 September, 2026 | 03:09

The Market Cap of Eris Lifesciences is ₹18064.3 Cr As on 04 September, 2026 | 03:09

The P/E ratio of Eris Lifesciences is 28.1 As on 04 September, 2026 | 03:09

The PB ratio of Eris Lifesciences is 4.5 As on 04 September, 2026 | 03:09

The 52 week High & Low of Eris Lifesciences is ₹1799/₹1200 respectively As on 04 September, 2026 | 03:09

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23